Belonging to a class of chemotherapy drugs called “plant alkaloids,” Taxotere acts as a cell inhibitor, ultimately stopping the replication of cancer cells. Also known by its generic, Docetaxel, Taxotere is given through an IV, and has been approved for the treatment of breast cancer, lung cancer, stomach cancer, head and neck cancer and metastatic prostate cancer. There is evidence that it may be able to treat ovarian, bladder, pancreatic and soft tissue sarcoma and melanoma-type cancers. Unfortunately, many women who underwent treatment for breast cancer with Taxotere are experiencing a permanent side effect that they were not previously aware of—hair loss, or alopecia.

While hair loss is a common side effect associated with chemotherapy drugs, hair typically grows back within a few months after treatment is complete. Yet, recent oncology studies have suggested that taxane chemotherapy drugs, including Taxotere, are responsible for permanent and severe hair loss. The FDA responded in 2015 by updating the safety information pertaining to Taxotere, stating permanent alopecia (hair loss) as a potential side effect. By this time, however, many women across the U.S. were already suffering from the distressing and long-term effects of hair loss from the drug.

For those diagnosed with breast and other cancers, health is your number one priority. Yet, if you’ve survived cancer and are attempting to move forward with your life, permanent hair loss can be devastating. Thus, if you are a breast cancer survivor and are suffering from permanent alopecia that you were not warned about, you need to know your legal options. The personal injury lawyers at the Harman Law Firm maintain a practice focus on defective drugs and seek justice for victims of physical, financial and emotional harm. We have the resources and experience to take on drug companies that have not issued proper warnings pertaining to their medications.

You’ve been through enough. Call the Harman Law Firm today to discuss your Taxotere-related injury. Your initial consultation is free.

Permanent Hair Loss Associated With Taxotere

Approximately 300,000 women are diagnosed with breast cancer every year, and Taxotere (Docetaxel) is the most prescribed chemotherapy drug in its class. However, multiple studies have linked Taxotere to permanent hair loss (Alopecia), and in some cases, the hair loss lasted for a decade or longer. As a result, breast cancer survivors are filing lawsuits against the drug company, Sanofi, alleging that they did not properly warn them of the risk. In turn, victims also claim that Sanofi hid research concerning Taxotere and its link to severe side effects.

If you or someone you love have survived breast cancer and are suffering from the disfiguring side effect of permanent hair loss, including sparse and clumpy hair regrowth, the attorneys at the Harman Law Firm are equipped with the knowledge and resources needed to hold drug companies accountable for misleading consumers about their drug or concealing important information about side effects, including permanent hair loss.

In the aftermath of your cancer journey, you deserve a better quality of life. The attorneys at the Harman Law Firm are here to help. We come alongside victims all across the U.S. who have experienced severe and negative health effects after taking a defective drug or medication. Contact us today for a free initial consultation to discuss your potential claim.